902837-47-2 Usage
Uses
Used in Pharmaceutical Industry:
2-(Cyclopentyloxy)-3-iodopyridine is utilized as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of drugs with specific therapeutic properties, contributing to the advancement of medicinal chemistry.
Used in Chemical Synthesis:
In the chemical synthesis industry, 2-(cyclopentyloxy)-3-iodopyridine serves as a key component in the creation of a range of organic compounds. Its reactivity and structural features facilitate the production of specialized chemicals for diverse applications.
Used as a Reagent in Organic Synthesis Reactions:
2-(Cyclopentyloxy)-3-iodopyridine is employed as a reagent in organic synthesis reactions, where its properties can be leveraged to drive specific chemical transformations. This role is crucial in the development of new chemical entities and the optimization of existing synthetic routes.
Used in Drug Development:
2-(CYCLOPENTYLOXY)-3-IODOPYRIDINE is also used in drug development, where its potential biological and pharmacological activities are harnessed to create new therapeutic agents. This application underscores its importance in the discovery and design of novel medications.
Check Digit Verification of cas no
The CAS Registry Mumber 902837-47-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,2,8,3 and 7 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 902837-47:
(8*9)+(7*0)+(6*2)+(5*8)+(4*3)+(3*7)+(2*4)+(1*7)=172
172 % 10 = 2
So 902837-47-2 is a valid CAS Registry Number.
902837-47-2Relevant articles and documents
BIARYL DERIVATIVE AS GPR120 AGONIST
-
Paragraph 0095; 0145, (2017/11/17)
The present invention relates to a biaryl derivative expressed by the chemical formula 1, a method for producing the biaryl derivative, a pharmaceutical composition comprising same, and use of same, the biaryl derivative expressed by the chemical formula 1, as a GPR120 agonist, promoting GLP-1 generation in the gastro-intestinal tract, reducing insulin resistance in the liver, muscles and the like from anti-inflammatory activity in the macrophage, pancreatic cells and the like, and allowing effective use in prevention or treatment of inflammation or metabolic diseases such as diabetes, complications from diabetes, obesity, non-alcoholic fatty liver disease, fatty liver disease, and osteoporosis.
